GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Qyuns Therapeutics Co Ltd (HKSE:02509) » Definitions » Tax Expense

Qyuns Therapeutics Co (HKSE:02509) Tax Expense : HK$-0.04 Mil (TTM As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Qyuns Therapeutics Co Tax Expense?

Qyuns Therapeutics Co's tax expense for the months ended in Jun. 2024 was HK$0.00 Mil. Its tax expense for the trailing twelve months (TTM) ended in Jun. 2024 was HK$-0.04 Mil.


Qyuns Therapeutics Co Tax Expense Historical Data

The historical data trend for Qyuns Therapeutics Co's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qyuns Therapeutics Co Tax Expense Chart

Qyuns Therapeutics Co Annual Data
Trend Dec21 Dec22 Dec23
Tax Expense
-0.09 -0.08 -0.08

Qyuns Therapeutics Co Quarterly Data
Dec21 Sep22 Dec22 Jun23 Sep23 Dec23 Jun24
Tax Expense Get a 7-Day Free Trial -0.02 - -0.02 -0.02 -

Qyuns Therapeutics Co Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$-0.04 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qyuns Therapeutics Co  (HKSE:02509) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Qyuns Therapeutics Co Tax Expense Related Terms

Thank you for viewing the detailed overview of Qyuns Therapeutics Co's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Qyuns Therapeutics Co Business Description

Traded in Other Exchanges
N/A
Address
No. 907 Yaocheng Avenue, Room 1310, Building 1, Taizhou, Jiangsu, CHN
Qyuns Therapeutics Co Ltd is a a clinical-stage biotech company focused on biologic therapies for autoimmune and allergic diseases, with a self-developed drug pipeline.
Executives
Zhu Jing
Taizhou Xinfu Tongxin Enterprise Management Partnership (limited Partnership)
Tai Zhou Yi Yao Gao Xin Ji Shu Chan Ye Tou Zi Fa Zhan You Xian Gong Si 2201 Interest of corporation controlled by you
Tai Zhou Yi Yao Gao Xin Qu Hua Yin Jin Rong Tou Zi You Xian Gong Si 2201 Interest of corporation controlled by you
Qing Dao Xin Chen Ke Chuang Shi Ye You Xian Gong Si
Zi Jin Xin Tuo You Xian Ze Ren Gong Si
Tai Zhou Hua Cheng Yi Xue Tou Zi Ji Tuan You Xian Gong Si
Nan Jing Zi Jin Tou Zi Ji Tuan You Xian Ze Ren Gong Si
Nan Jing Shi Guo You Zi Chan Tou Zi Guan Li Kong Gu Ji Tuan You Xian Ze Ren Gong Si
Bei Jing Hong Tai Tong Chuang Tou Zi Guan Li You Xian Gong Si
Sheng Xi Tai
Tai Zhou Yi Yao Cheng Kong Gu Ji Tuan You Xian Gong Si 2201 Interest of corporation controlled by you
Hu Kaijun 2201 Interest of corporation controlled by you
Yu Guo'an
Hangzhou Quanyi Investment Management Partnership (general Partnership)

Qyuns Therapeutics Co Headlines

No Headlines